ADVERTISEMENT
Search

ADVERTISEMENT
 

Pharmacy Today logo

Potential changes coming for nonprescription CBD products
Drugs & Diseases

CBD

Potential changes coming for nonprescription CBD products

Over a decade has passed since the first states, Colorado and Washington, legalized cannabis for recreational use. Another 5 years have gone by since the Farm Bill allowed for the sale of hemp and its derived products. And over the past several years, many states have passed legislation allowing cannabis to be used medically. But questions remain.

Ariel L. Clark, PharmD

Psyllium husk and weight loss
Drugs & Diseases

On The Shelf

Psyllium husk and weight loss

Weight loss is big business, and the popularity of Ozempic, the FDA-approved prescription T2D drug, was boosted by those using it off-label for weight loss. Called “the poor man’s Ozempic,” psyllium husk is enjoying a rise in interest as an affordable alternative to semaglutide. But does it deliver on the promise of weight loss?

Mickie Cathers

Phenylephrine: The story of  an ineffective nasal decongestant
Drugs & Diseases

OTCs Today

Phenylephrine: The story of an ineffective nasal decongestant

On September 12, 2023, the FDA Nonprescription Drugs Advisory Committee unanimously agreed that oral phenylephrine is ineffective, setting the stage for FDA to require its removal from hundreds of nonprescription products. But why did it take so long for a decongestant that patients claimed didn’t work to be brought to the committee for evaluation?

Mary Warner

A joint effort: Cannabis update for pharmacists
CPE

CPE

A joint effort: Cannabis update for pharmacists

It’s natural! Yet, as with any substance, chemical, and medication on this planet, it comes with its own baggage. Hence the circular and polarized conversations emanating across our country and globe.

Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, WVU School of Pharmacy, Morgantown, WV

RSS
123
ADVERTISEMENT